Shanghai Universal Biotech Co Ltd
SZSE:301166
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
S
|
Shanghai Universal Biotech Co Ltd
SZSE:301166
|
2.9B CNY |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
116.2B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
68.5B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.9B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
52.1B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.3B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.8B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.8B CNY |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.1B HKD |
Loading...
|
Market Distribution
| Min | -409 046.1% |
| 30th Percentile | -1.4% |
| Median | 4.2% |
| 70th Percentile | 10.3% |
| Max | 876.4% |
Other Profitability Ratios
Shanghai Universal Biotech Co Ltd
Glance View
Shanghai Universal Biotech Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 493 full-time employees. The company went IPO on 2021-12-28. Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The firm is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Shanghai Universal Biotech Co Ltd is -5.1%, which is below its 3-year median of -0.6%.
Over the last 3 years, Shanghai Universal Biotech Co Ltd’s Operating Margin has decreased from 8.8% to -5.1%. During this period, it reached a low of -5.1% on Oct 30, 2025 and a high of 8.8% on Aug 30, 2022.
